Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: D.Lu who wrote (232)	3/10/1999 12:08:00 PM
From: scaram(o)uche	Read Replies (3) \| Respond to of 1475

The Zenapax results look great. I hope that the MEDI/BTRN/507 results will be better, only a little from the stand of investor. Time will tell. I have a very personal interest in GvH. I was a grad student at UCLA when BMT was a new experimental therapy, considering the PH.D./M.D. program. Bob Gale presented a seminar where photos were shown of some of the initial patients. I got physically ill, and decided that close contact with patients was not in my cards. GvH is a man-made disease. When it is overcome, we will have a miracle therapy that will save many young lives and maneuver the tragedy that strikes too many young families. Of interest, I was intimately involved in some of Nancy Kernan's earlier attempts to beat GvH with an anti-CD5 ricin conjugate. That's also how I got involved in early MAb humanization efforts. I follow progress in the field closely. BTRN is not just an investment for me. It is a company and effort that I passionately believe in. I can't comment on PDLI as an investment.